CD40LG and B-cell chronic lymphocytic leukemia: MiR-181b plays a role also in immune response regulation: recently, Di Marco and colleagues demonstrated that miR-181b modulates T cells’ cytotoxic activity against CLL cells: firstly, the author found that the expression of miR-181b increases in CLL cells by CD40-CD40L interaction.